235
Views
0
CrossRef citations to date
0
Altmetric
Special Report

The Role of miRNAs in Endometrial Cancer

, , , &
Pages 951-959 | Published online: 07 Oct 2015

References

  • Lee RC , FeinbaumRL , AmbrosV . The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 . Cell75 ( 5 ), 843 – 854 ( 1993 ).
  • Wightman B , HaI , RuvkunG . Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans . Cell75 ( 5 ), 855 – 862 ( 1993 ).
  • Bueno MJ , Perez De CastroI , MalumbresM . Control of cell proliferation pathways by microRNAs . Cell Cycle7 ( 20 ), 3143 – 3148 ( 2008 ).
  • Engels BM , HutvagnerG . Principles and effects of microRNA-mediated post-transcriptional gene regulation . Oncogene25 ( 46 ), 6163 – 6169 ( 2006 ).
  • Jovanovic M , HengartnerMO . miRNAs and apoptosis: RNAs to die for . Oncogene25 ( 46 ), 6176 – 6187 ( 2006 ).
  • Lewis BP , BurgeCB , BartelDP . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets . Cell120 ( 1 ), 15 – 20 ( 2005 ).
  • Ambros V , ChenX . The regulation of genes and genomes by small RNAs . Development134 ( 9 ), 1635 – 1641 ( 2007 ).
  • Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function . Cell116 ( 2 ), 281 – 297 ( 2004 ).
  • Lim LP , LauNC , Garrett-EngelePet al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs . Nature433 ( 7027 ), 769 – 773 ( 2005 ).
  • Rodriguez A , Griffiths-JonesS , AshurstJL , BradleyA . Identification of mammalian microRNA host genes and transcription units . Genome Res.14 ( 10A ), 1902 – 1910 ( 2004 ).
  • Cai X , HagedornCH , CullenBR . Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs . RNA10 ( 12 ), 1957 – 1966 ( 2004 ).
  • Lee Y , KimM , HanJet al. MicroRNA genes are transcribed by RNA polymerase II . Embo. J.23 ( 20 ), 4051 – 4060 ( 2004 ).
  • Lee Y , AhnC , HanJet al. The nuclear RNase III Drosha initiates microRNA processing . Nature425 ( 6956 ), 415 – 419 ( 2003 ).
  • Denli AM , TopsBB , PlasterkRH , KettingRF , HannonGJ . Processing of primary microRNAs by the microprocessor complex . Nature432 ( 7014 ), 231 – 235 ( 2004 ).
  • Gregory RI , YanKP , AmuthanGet al. The microprocessor complex mediates the genesis of microRNAs . Nature432 ( 7014 ), 235 – 240 ( 2004 ).
  • Han J , LeeY , YeomKH , KimYK , JinH , KimVN . The Drosha-DGCR8 complex in primary microRNA processing . Genes Dev.18 ( 24 ), 3016 – 3027 ( 2004 ).
  • Yeom KH , LeeY , HanJ , SuhMR , KimVN . Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing . Nucleic Acids Res.34 ( 16 ), 4622 – 4629 ( 2006 ).
  • Yi R , QinY , MacaraIG , CullenBR . Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs . Genes Dev.17 ( 24 ), 3011 – 3016 ( 2003 ).
  • Lee Y , HurI , ParkSY , KimYK , SuhMR , KimVN . The role of PACT in the RNA silencing pathway . Embo. J.25 ( 3 ), 522 – 532 ( 2006 ).
  • Saito K , IshizukaA , SiomiH , SiomiMC . Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells . PLoS Biol.3 ( 7 ), e235 ( 2005 ).
  • Khvorova A , ReynoldsA , JayasenaSD . Functional siRNAs and miRNAs exhibit strand bias . Cell115 ( 2 ), 209 – 216 ( 2003 ).
  • Schwarz DS , HutvagnerG , DuT , XuZ , AroninN , ZamorePD . Asymmetry in the assembly of the RNAi enzyme complex . Cell115 ( 2 ), 199 – 208 ( 2003 ).
  • Bryant A , LutherborrowM , MaD . The clinicopathological relevance of microRNA in normal and malignant haematopoiesis . Pathology41 ( 3 ), 204 – 213 ( 2009 ).
  • Lytle JR , YarioTA , SteitzJA . Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR . Proc. Natl Acad. Sci. USA104 ( 23 ), 9667 – 9672 ( 2007 ).
  • Doench JG , SharpPA . Specificity of microRNA target selection in translational repression . Genes Dev.18 ( 5 ), 504 – 511 ( 2004 ).
  • miRBase . www.mirbase.org/ .
  • Waldman SA , TerzicA . A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer . Febs J.276 ( 8 ), 2157 – 2164 ( 2009 ).
  • Siegel RL , MillerKD , JemalA . Cancer statistics, 2015 . CA Cancer J. Clin.65 ( 1 ), 5 – 29 ( 2015 ).
  • Salvesen HB , HaldorsenIS , TrovikJ . Markers for individualised therapy in endometrial carcinoma . Lancet Oncol.13 ( 8 ), e353 – e361 ( 2012 ).
  • Setiawan VW , YangHP , PikeMCet al. Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31 ( 20 ), 2607 – 2618 ( 2013 ).
  • Matias-Guiu X , DavidsonB . Prognostic biomarkers in endometrial and ovarian carcinoma . Virchows Arch.464 ( 3 ), 315 – 331 ( 2014 ).
  • Abu-Rustum NR . Update on sentinel node mapping in uterine cancer: 10-year experience at Memorial Sloan-Kettering Cancer Center . J. Obstet. Gynaecol. Res.40 ( 2 ), 327 – 334 ( 2014 ).
  • Dowdy SC . Improving oncologic outcomes for women with endometrial cancer: realigning our sights . Gynecol. Oncol.133 ( 2 ), 370 – 374 ( 2014 ).
  • Permuth-Wey J , LawrensonK , ShenHCet al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 . Nat. Commun.4 , 1627 ( 2013 ).
  • Shih KK , QinLX , TannerEJet al. A microRNA survival signature (MiSS) for advanced ovarian cancer . Gynecol. Oncol.121 ( 3 ), 444 – 450 ( 2011 ).
  • Boren T , XiongY , HakamAet al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis . Gynecol. Oncol.110 ( 2 ), 206 – 215 ( 2008 ).
  • Chung TK , CheungTH , HuenNYet al. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women . Int. J. Cancer.124 ( 6 ), 1358 – 1365 ( 2009 ).
  • Hiroki E , AkahiraJ , SuzukiFet al. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas . Cancer Sci.101 ( 1 ), 241 – 249 ( 2010 ).
  • Ratner ES , TuckD , RichterCet al. MicroRNA signatures differentiate uterine cancer tumor subtypes . Gynecol Oncol.118 ( 3 ), 251 – 257 ( 2010 ).
  • Wu W , LinZ , ZhuangZ , LiangX . Expression profile of mammalian microRNAs in endometrioid adenocarcinoma . Eur. J. Cancer Prev.18 ( 1 ), 50 – 55 ( 2009 ).
  • Danielson LS , MenendezS , AttoliniCSet al. A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy . Am. J. Pathol.177 ( 2 ), 908 – 917 ( 2010 ).
  • Devor EJ , HoveyAM , GoodheartMJ , RamachandranS , LeslieKK . microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs . Oncol. Rep.26 ( 4 ), 995 – 1002 ( 2011 ).
  • Torres A , TorresK , PaszkowskiTet al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer . Tumour Biol.32 ( 4 ), 769 – 776 ( 2011 ).
  • Snowdon J , ZhangX , ChildsT , TronVA , FeilotterH . The microRNA-200 family is upregulated in endometrial carcinoma . PLoS ONE6 ( 8 ), e22828 ( 2011 ).
  • Wu Y , LiuS , XinHet al. Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells . Cancer117 ( 17 ), 3989 – 3998 ( 2011 ).
  • Zhang X , DongY , TiHet al. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas . Hum. Pathol.44 ( 11 ), 2571 – 2580 ( 2013 ).
  • Reinhart BJ , SlackFJ , BassonMet al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans . Nature403 ( 6772 ), 901 – 906 ( 2000 ).
  • Akao Y , NakagawaY , NaoeT . let-7 microRNA functions as a potential growth suppressor in human colon cancer cells . Biol. Pharm. Bull.29 ( 5 ), 903 – 906 ( 2006 ).
  • Bussing I , SlackFJ , GrosshansH . let-7 microRNAs in development, stem cells and cancer . Trends Mol. Med.14 ( 9 ), 400 – 409 ( 2008 ).
  • Takamizawa J , KonishiH , YanagisawaKet al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival . Cancer Res.64 ( 11 ), 3753 – 3756 ( 2004 ).
  • Vasilatou D , PapageorgiouSG , KontsiotiFet al. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes . Leuk Res.37 ( 3 ), 251 – 258 ( 2013 ).
  • Yu F , YaoH , ZhuPet al. let-7 regulates self renewal and tumorigenicity of breast cancer cells . Cell131 ( 6 ), 1109 – 1123 ( 2007 ).
  • Creighton CJ , Hernandez-HerreraA , JacobsenAet al. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma . PLoS One7 ( 3 ), e34546 ( 2012 ).
  • Johnson SM , GrosshansH , ShingaraJet al. RAS is regulated by the let-7 microRNA family . Cell120 ( 5 ), 635 – 647 ( 2005 ).
  • Kumar MS , LuJ , MercerKL , GolubTR , JacksT . Impaired microRNA processing enhances cellular transformation and tumorigenesis . Nat. Genet.39 ( 5 ), 673 – 677 ( 2007 ).
  • Lee YS , DuttaA . The tumor suppressor microRNA let-7 represses the HMGA2 oncogene . Genes Dev.21 ( 9 ), 1025 – 1030 ( 2007 ).
  • Park SM , ShellS , RadjabiARet al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 . Cell Cycle6 ( 21 ), 2585 – 2590 ( 2007 ).
  • Liu P , QiM , MaC , LaoG , LiuY . Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B . FEBS Lett.587 ( 16 ), 2523 – 2529 ( 2013 ).
  • Jiang F , LiuT , HeYet al. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo . BMC Cancer11 , 425 ( 2011 ).
  • Yu D , ZhouH , XunQ , XuX , LingJ , HuY . microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3 . Oncol. Lett.3 ( 6 ), 1221 – 1226 ( 2012 ).
  • Dong P , KaraayvazM , JiaNet al. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis . Oncogene32 ( 27 ), 3286 – 3295 ( 2013 ).
  • Qin X , YanL , ZhaoX , LiC , FuY . microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer . Oncol Lett.4 ( 6 ), 1290 – 1296 ( 2012 ).
  • Kraljevic Pavelic S , SedicM , BosnjakH , SpaventiS , PavelicK . Metastasis: new perspectives on an old problem . Mol. Cancer10 , 22 ( 2011 ).
  • Romero-Perez L , Lopez-GarciaMA , Diaz-MartinJet al. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma . Mod Pathol.26 ( 11 ), 1514 – 1524 ( 2013 ).
  • Park SM , GaurAB , LengyelE , PeterME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 . Genes Dev.22 ( 7 ), 894 – 907 ( 2008 ).
  • Korpal M , LeeES , HuG , KangY . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 . J. Biol. Chem.283 ( 22 ), 14910 – 14914 ( 2008 ).
  • Gregory PA , BertAG , PatersonELet al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 . Nat. Cell Biol.10 ( 5 ), 593 – 601 ( 2008 ).
  • Bai JX , YanB , ZhaoZNet al. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines . Endocrinology154 ( 2 ), 635 – 645 ( 2013 ).
  • Dong P , KaneuchiM , WatariHet al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 . Mol. Cancer10 , 99 ( 2011 ).
  • Dong P , KaneuchiM , WatariH , SudoS , SakuragiN . MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines . Mol. Carcinog.53 ( 5 ), 349 – 359 ( 2014 ).
  • Li BL , LuC , LuWet al. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer . Med. Oncol.30 ( 1 ), 484 ( 2013 ).
  • Braconi C , HuangN , PatelT . MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes . Hepatology51 ( 3 ), 881 – 890 ( 2010 ).
  • Chen Y , SongY , WangZet al. Altered expression of miR-148a and miR-152 in gastrointestinal cancers and its clinical significance . J. Gastrointest. Surg.14 ( 7 ), 1170 – 1179 ( 2010 ).
  • Stumpel DJ , SchotteD , Lange-TurenhoutEAet al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale . Leukemia25 ( 3 ), 429 – 439 ( 2011 ).
  • Tsuruta T , KozakiK , UesugiAet al. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer . Cancer Res.71 ( 20 ), 6450 – 6462 ( 2011 ).
  • Jiang L , MengW , ZengJ , HuH , LuL . MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis . Cell Biol. Int.37 ( 6 ), 577 – 583 ( 2013 ).
  • Hamano R , MiyataH , YamasakiMet al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway . Clin. Cancer Res.17 ( 9 ), 3029 – 3038 ( 2011 ).
  • Lee JW , ParkYA , ChoiJJet al. The expression of the miRNA-200 family in endometrial endometrioid carcinoma . Gynecol. Oncol.120 ( 1 ), 56 – 62 ( 2011 ).
  • Wu Y , XiaoY , DingXet al. A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2alpha gene is associated with cisplatin resistance . PLoS ONE6 ( 12 ), e29043 ( 2011 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.